| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INR
|
Biedermann, Joseph S.
|
|
2015
|
136 |
3 |
p. 652-657
6 p.
|
artikel
|
| 2 |
A new method to quantify β-antithrombin glycoform in plasma reveals increased levels during the acute stroke event
|
de la Morena-Barrio, M.E.
|
|
2015
|
136 |
3 |
p. 634-641
8 p.
|
artikel
|
| 3 |
Association between genetic polymorphisms and deep vein thrombosis in a Chinese population
|
Jiang, Jianjun
|
|
2015
|
136 |
3 |
p. 687-689
3 p.
|
artikel
|
| 4 |
Association between red cell distribution width and risk of venous thromboembolism
|
Bucciarelli, Paolo
|
|
2015
|
136 |
3 |
p. 590-594
5 p.
|
artikel
|
| 5 |
A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy
|
Fabbri, Alessia
|
|
2015
|
136 |
3 |
p. 613-619
7 p.
|
artikel
|
| 6 |
Autophagy protein 5 enhances the function of rat EPCs and promotes EPCs homing and thrombus recanalization via activating AKT
|
Hu, Nan
|
|
2015
|
136 |
3 |
p. 642-651
10 p.
|
artikel
|
| 7 |
Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism
|
Faiz, Ambarina S.
|
|
2015
|
136 |
3 |
p. 535-541
7 p.
|
artikel
|
| 8 |
Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal
|
Voils, Stacy A.
|
|
2015
|
136 |
3 |
p. 595-598
4 p.
|
artikel
|
| 9 |
Comparison of the Performance of the Warfarin Pharmacogenetics Algorithms in Patients with Surgery of Heart Valve Replacement and Heart Valvuloplasty
|
Xu, Hang
|
|
2015
|
136 |
3 |
p. 552-559
8 p.
|
artikel
|
| 10 |
Could perioperative bleeding complications be predicted using a platelet aggregation test?
|
Sueta, Daisuke
|
|
2015
|
136 |
3 |
p. 491-492
2 p.
|
artikel
|
| 11 |
Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals
|
Starikova, Irina
|
|
2015
|
136 |
3 |
p. 566-572
7 p.
|
artikel
|
| 12 |
Effect of the Novel Biodegradable N, O-Carboxymethylchitosan and Oligo-Chitosan on the Platelet Thrombogenicity Cascade in von Willebrand Disease
|
Periayah, Mercy Halleluyah
|
|
2015
|
136 |
3 |
p. 625-633
9 p.
|
artikel
|
| 13 |
Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients
|
Wildhagen, Karin C.A.A.
|
|
2015
|
136 |
3 |
p. 542-547
6 p.
|
artikel
|
| 14 |
Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study
|
Zöller, Bengt
|
|
2015
|
136 |
3 |
p. 573-581
9 p.
|
artikel
|
| 15 |
How to avoid venous thromboembolism in women at increased risk – with special focus on low-risk periods
|
Lindqvist, Pelle G.
|
|
2015
|
136 |
3 |
p. 513-518
6 p.
|
artikel
|
| 16 |
Intracranial haemorrhage in patients treated with direct oral anticoagulants
|
Beynon, Christopher
|
|
2015
|
136 |
3 |
p. 560-565
6 p.
|
artikel
|
| 17 |
In vitro anti-platelet potency of ticagrelor in blood samples from infants and children
|
Söderlund, Fredrik
|
|
2015
|
136 |
3 |
p. 620-624
5 p.
|
artikel
|
| 18 |
Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study
|
Lessire, Sarah
|
|
2015
|
136 |
3 |
p. 693-696
4 p.
|
artikel
|
| 19 |
Mechanisms of hypercoagulability in nephrotic syndrome associated with membranous nephropathy as assessed by thromboelastography
|
Huang, Meng-jie
|
|
2015
|
136 |
3 |
p. 663-668
6 p.
|
artikel
|
| 20 |
Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention
|
Cetin, Mehmet Serkan
|
|
2015
|
136 |
3 |
p. 599-605
7 p.
|
artikel
|
| 21 |
Paradoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin
|
Furugohri, Taketoshi
|
|
2015
|
136 |
3 |
p. 658-662
5 p.
|
artikel
|
| 22 |
Practice variation in the management of distal deep vein thrombosis in primary vs. secondary cares: A clinical practice survey
|
Almosni, Jennifer
|
|
2015
|
136 |
3 |
p. 526-530
5 p.
|
artikel
|
| 23 |
Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery
|
Plicner, Dariusz
|
|
2015
|
136 |
3 |
p. 519-525
7 p.
|
artikel
|
| 24 |
Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapy
|
Jacobsen, Christine
|
|
2015
|
136 |
3 |
p. 673-681
9 p.
|
artikel
|
| 25 |
Reliability of diagnosing incidental pulmonary embolism in cancer patients
|
den Exter, Paul L.
|
|
2015
|
136 |
3 |
p. 531-534
4 p.
|
artikel
|
| 26 |
Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement
|
Blasi, Annabel
|
|
2015
|
136 |
3 |
p. 669-672
4 p.
|
artikel
|
| 27 |
Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation
|
Casonato, A.
|
|
2015
|
136 |
3 |
p. 682-686
5 p.
|
artikel
|
| 28 |
The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital
|
Yang, Yong
|
|
2015
|
136 |
3 |
p. 548-551
4 p.
|
artikel
|
| 29 |
The JAK2 V617F mutational status and allele burden
|
Liang, Shanshan
|
|
2015
|
136 |
3 |
p. 690-
1 p.
|
artikel
|
| 30 |
The JAK2 V617F mutational status and allele burden – authors’ reply
|
Borowczyk, Martyna
|
|
2015
|
136 |
3 |
p. 691-692
2 p.
|
artikel
|
| 31 |
Thrombosis in vasculitic disorders−clinical manifestations, pathogenesis and management
|
Katz, Ofrat Beyar
|
|
2015
|
136 |
3 |
p. 504-512
9 p.
|
artikel
|
| 32 |
Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants
|
Posch, Florian
|
|
2015
|
136 |
3 |
p. 582-589
8 p.
|
artikel
|
| 33 |
Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
|
Friedman, Eitan A.
|
|
2015
|
136 |
3 |
p. 493-503
11 p.
|
artikel
|
| 34 |
Von Willebrand factor-A1 domain binds platelet glycoprotein Ibα in multiple states with distinctive force-dependent dissociation kinetics
|
Ju, Lining
|
|
2015
|
136 |
3 |
p. 606-612
7 p.
|
artikel
|
Tijdschrift beschrijving